日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma

低级别浆液性卵巢癌的不同组织病理学特征与分子亚型和预后相关

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-34627-5
Hollis, Robert L; Thomson, John P; van Baal, Juliette; Ilenkovan, Narthana; Churchman, Michael; van de Vijver, Koen; Dijk, Frederike; Meynert, Alison M; Bartos, Clare; Rye, Tzyvia; Croy, Ian; Diana, Patricia; van Gent, Mignon; Creedon, Helen; Nirsimloo, Rachel; Lok, Christianne; Gourley, Charlie; Herrington, C Simon
肿瘤
肿瘤免疫
卵巢癌
发表日期：2023
文献求助 收藏

Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

高级别浆液性卵巢癌的多组学表征可实现高分辨率的患者分层

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-0368
Hollis, Robert L; Meynert, Alison M; Michie, Caroline O; Rye, Tzyvia; Churchman, Michael; Hallas-Potts, Amelia; Croy, Ian; McCluggage, W Glenn; Williams, Alistair R W; Bartos, Clare; Iida, Yasushi; Okamoto, Aikou; Dougherty, Brian; Barrett, J Carl; March, Ruth; Matakidou, Athena; Roxburgh, Patricia; Semple, Colin A; Harkin, D Paul; Kennedy, Richard; Herrington, C Simon; Gourley, Charlie
肿瘤
肿瘤免疫
卵巢癌
发表日期：2022
文献求助 收藏

Structural Variants at the BRCA1/2 Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma

BRCA1/2基因位点的结构变异是高级别浆液性卵巢癌同源修复缺陷的常见原因

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-20-4068
Ewing, Ailith; Meynert, Alison; Churchman, Michael; Grimes, Graeme R; Hollis, Robert L; Herrington, C Simon; Rye, Tzyvia; Bartos, Clare; Croy, Ian; Ferguson, Michelle; Lennie, Mairi; McGoldrick, Trevor; McPhail, Neil; Siddiqui, Nadeem; Dowson, Suzanne; Glasspool, Rosalind; Mackean, Melanie; Nussey, Fiona; McDade, Brian; Ennis, Darren; McMahon, Lynn; Matakidou, Athena; Dougherty, Brian; March, Ruth; Barrett, J Carl; McNeish, Iain A; Biankin, Andrew V; Roxburgh, Patricia; Gourley, Charlie; Semple, Colin A
BRCA1
肿瘤
肿瘤免疫
卵巢癌
发表日期：2021
文献求助 收藏

Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification

子宫内膜样卵巢癌的综合分子特征分析揭示了分层的机会

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-021-00187-y
Hollis, Robert L; Stanley, Barbara; Thomson, John P; Churchman, Michael; Croy, Ian; Rye, Tzyvia; Bartos, Clare; Nussey, Fiona; Mackean, Melanie; Meynert, Alison M; Semple, Colin A; Gourley, Charlie; Herrington, C Simon
肿瘤
肿瘤免疫
卵巢癌
发表日期：2021
文献求助 收藏

Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma

黏液性卵巢癌复发风险和生存的临床病理决定因素

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers13225839
Hollis, Robert L; Stillie, Lorna J; Hopkins, Samantha; Bartos, Clare; Churchman, Michael; Rye, Tzyvia; Nussey, Fiona; Fegan, Scott; Nirsimloo, Rachel; Inman, Gareth J; Herrington, C Simon; Gourley, Charlie
卵巢癌
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome

子宫内膜样卵巢癌的分子分层可预测临床结局

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-020-18819-5
Hollis, Robert L; Thomson, John P; Stanley, Barbara; Churchman, Michael; Meynert, Alison M; Rye, Tzyvia; Bartos, Clare; Iida, Yasushi; Croy, Ian; Mackean, Melanie; Nussey, Fiona; Okamoto, Aikou; Semple, Colin A; Gourley, Charlie; Herrington, C Simon
肿瘤
肿瘤免疫
卵巢癌
发表日期：2020
文献求助 收藏

Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment

卵巢癌中糖酵解酶的表达以及对糖酵解途径作为卵巢癌治疗策略的评估

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-018-4521-4
Chrysi Xintaropoulou, Carol Ward, Alan Wise, Suzanna Queckborner, Arran Turnbull, Caroline O Michie, Alistair R W Williams, Tzyvia Rye, Charlie Gourley, Simon P Langdon
肿瘤
卵巢癌
发表日期：2018
文献求助 收藏

Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations

增强聚乙二醇化脂质体阿霉素对携带 BRCA1 和 BRCA2 异常的高级别浆液性卵巢癌的疗效

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-017-3981-2
Hollis, Robert L; Meynert, Alison M; Churchman, Michael; Rye, Tzyvia; Mackean, Melanie; Nussey, Fiona; Arends, Mark J; Sims, Andrew H; Semple, Colin A; Herrington, C Simon; Gourley, Charlie
肿瘤
肿瘤免疫
BRCA2
卵巢癌
BRCA1
发表日期：2018
文献求助 收藏

Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer

携带 BRCA1/2 基因突变的晚期卵巢癌患者对 PARP 抑制剂奥拉帕尼抗肿瘤反应的基线临床预测因子

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.17005
Rafii, Saeed; Gourley, Charlie; Kumar, Rajiv; Geuna, Elena; Ern Ang, Joo; Rye, Tzyvia; Chen, Lee-May; Shapira-Frommer, Ronnie; Friedlander, Michael; Matulonis, Ursula; De Greve, Jacques; Oza, Amit M; Banerjee, Susana; Molife, L Rhoda; Gore, Martin E; Kaye, Stan B; Yap, Timothy A
肿瘤
肿瘤免疫
卵巢癌
BRCA1
PARP
发表日期：2017
文献求助 收藏